AACR Atlanta – Targeted external or internal radiotherapy in combination with immunotherapies and companion imaging diagnostics

AACR Atlanta – Induction of immunogenic cell death and enhancement of dendritic cell function

AACR Atlanta – Immune Checkpoint Blockade and Autoimmune Diseases

Immuno-Oncology Summit Europe – Development of Pre-Clinical Assays to Support Drug Discovery Programs in Immuno-Oncology

[FR] Oncodesign amène un « derisking » important et cela est de plus en plus perçu par les investissseurs

Boursier.com – Oncodesign amène un « derisking » important et cela est de plus en plus perçu par les investissseurs

[EN] How to better predict the effect of cancer immunotherapy? Tailored-made humanized mouse models are the key solution!

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model

Service partnership agreement between Oncodesign and Galderma

Press Release: Multi-year service contract: design and discover new drug candidates in dermatology - Galderma.

Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice

Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice

Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress

Presentation of detailed results from the first two stages of the clinical trial in lung cancer | 31st EANM1 | 2018.

Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED

Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.